Prostate Screening Current Events | Prostate Screening News | 11
|
| Page
11 of
47 |
924 Results |
|
|
|
Sort By:
Page Views | Date |
Vitamin D inhibits progression of some prostate cancers
Vitamin D can inhibit the spread of prostate cancer cells by limiting the activity of two specific enzymes, University of Rochester Medical Center scientists report. view more (2006-02-09)
Screening children for speech problems is ineffective
Both parental concerns and screening for speech and language problems fail to identify many preschool children needing therapy, finds a study in this week's BMJ. Researchers set out to compare the performance of two methods for identifying speech and language problems in preschool children in a deprived inner city area of London. They randomly... view more... (2002-11-13)
Flavonoids may inhibit prostate cancer
Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer. view more (2005-10-21)
Lung cancer screening regimen provides opportunity for cure
Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology. view more (2007-03-27)
Plea To Lower Age For Mammography Screening In The UK (p 246)
Two leading UK cancer experts are calling for the entry age for mammographic screening for breast cancer to be reduced from 50 to 47 years for women in the UK. Their rationale is detailed in a correspondence letter in this week's issue of THE LANCET. Screening mammography became widely available from the UK National Health Service in the late... view more... (2003-07-16)
Proactive chlamydia screening is not good value for money
Proactive chlamydia screening for young adults is an expensive intervention that probably does not represent good value for money, concludes a study published on bmj.com today. view more (2007-07-27)
New drug to treat enlarged prostate developed at UCL
Millions of men stand to benefit from new method of treatment for enlarged prostate view more (2003-11-27)
1 disease, not 1 demographic
The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." view more (2009-10-30)
Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. view more (2009-07-02)
Experimental agent blocks prostate cancer in animal study
An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. view more (2008-05-23)
Blood vessels might predict prostate cancer behavior
A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? view more (2009-11-04)
Reducing intake of dietary fat prevents prostate cancer in mice
Scientists with UCLA's Jonsson Cancer Center and the Department of Urology have showed that lowering intake of the type of fat common in a Western diet helps prevent prostate cancer in mice, the first finding of its kind in a mouse model that closely mimics human cancer, researchers said. view more (2008-05-15)
Study finds gene linked to aggressive prostate cancer
Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive prostate cancer. view more (2007-12-12)
Scientists discover anti-cancer mechanism that arrests early prostate cancer
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. view more (2005-08-04)
New study shows that a cough medicine ingredient could effectively treat prostate cancer
A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. view more (2008-12-19)
Random drug testing in schools is unworkable
Random drug testing in schools is unworkable because schools could not satisfy government criteria for introducing new screening programmes, claims a public health expert in this week's BMJ. The Department of Health has 19 criteria for introducing new screening programmes. At least 18 of these are not met for widespread drug urine analysis in... view more... (2004-03-10)
Scientists design a PSA-activated protoxin that kills prostate cancer
Scientists have found a way of using a protein made by prostate cancer to target and kill the cancer cells themselves. In preliminary studies the new therapy affected only the prostate, without causing damage to other healthy tissues, and now it is being tested in a phase I clinical trial. view more (2006-11-10)
Screening for colorectal cancer detects unrecognized disease
Screening for colorectal cancer detects four out of ten cancers and should be carefully designed to be more effective, according to a study published today on bmj.com. view more (2008-11-21)
Prostate cancer research may be faster with PSA endpoints
A new study from Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia, who are members of the Southwest Oncology Group (SWOG), suggests that certain changes in prostate-specific antigen (PSA) levels may serve as surrogate endpoints for prostate cancer survival. view more (2006-04-19)
Men treated for localized prostate cancer could benefit from pomegranate juice consumption
Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence, according to new long-term research results being presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). view more (2009-04-27)
|
|
| Page
11 of
47 |
924 Results |
|
|
|
Sort By:
Page Views | Date |
|
